Sanofi Genzyme Competitors and Similar CompaniesClear all
Sanofi Genzyme's competitors and similar companies include Biogen, Amgen, Amicus Therapeutics and Gero.
 Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Gero Gero is a biotechnology company intended to evaluate the personal risks of mortality and health. | |
Founding Date | Founding Date 1981 | Founding Date 1978 | Founding Date 1980 | Founding Date 2002 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Singapore, SG HQ Agios Athanasios, CY Moskva, RU |
Employees | Employees 9,9041% decrease | Employees 7,57013% decrease | Employees 25,200 | Employees 58415% increase | Employees 132 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) 170.4 b | Valuation ($) 3.4 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $9.8b (FY, 2023) | Revenue (est.) $28.2b (FY, 2023) | Revenue (est.) $399.4m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $2.5b (FY, 2023) | Cost of goods $8.5b (FY, 2023) | Cost of goods $37.3m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $7.3b (FY, 2023) | Gross profit $19.7b (FY, 2023) | Gross profit $362m (FY, 2023) | Gross profit N/A |
Net income | Net income N/A | Net income $1.2b (FY, 2023) | Net income $6.7b (FY, 2023) | Net income ($151.6m) (FY, 2023) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries 100 (Nov, 2020) | Countries N/A | Countries 100 (FY, 2020) | Countries N/A | Countries N/A |
Patents (US) | Patents (US) 605 (Nov, 2020) | Patents (US) 21 (FY, 2021) | Patents (US) 31 (FY, 2020) | Patents (US) N/A | Patents (US) N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 10 (Q2, 2022) | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 8 (Q2, 2022) | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 9 (Q2, 2022) | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88m | Total funding raised $ 7.5m |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,570↓ 13% decrease
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyAmgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companyGero
HQ
Singapore, SG
Employees
132
Gero is a biotechnology company intended to evaluate the personal risks of mortality and health.
View company